Deutsche Bank’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-166,841
| Closed | -$12M | – | 3714 |
|
|
2025
Q4 | $12M | Sell |
166,841
-97,773
| -37% | -$6.32M | ﹤0.01% | 1024 |
|
|
2025
Q3 | $11.5M | Buy |
264,614
+23,611
| +10% | +$954K | ﹤0.01% | 1011 |
|
|
2025
Q2 | $6.84M | Buy |
241,003
+56,388
| +31% | +$1.68M | ﹤0.01% | 1115 |
|
|
2025
Q1 | $5.45M | Sell |
184,615
-8,971
| -5% | -$279K | ﹤0.01% | 1216 |
|
|
2024
Q4 | $5.63M | Buy |
193,586
+30,340
| +19% | +$1.27M | ﹤0.01% | 1280 |
|
|
2024
Q3 | $7.5M | Buy |
163,246
+16,676
| +11% | +$724K | ﹤0.01% | 1118 |
|
|
2024
Q2 | $5.99M | Buy |
146,570
+11,821
| +9% | +$339K | ﹤0.01% | 1176 |
|
|
2024
Q1 | $3.44M | Sell |
134,749
-628,100
| -82% | -$9.84M | ﹤0.01% | 1420 |
|
|
2023
Q4 | $6.9M | Buy |
762,849
+628,299
| +467% | +$4.2M | ﹤0.01% | 1129 |
|
|
2023
Q3 | $858K | Buy |
134,550
+4,748
| +4% | +$40.9K | ﹤0.01% | 1826 |
|
|
2023
Q2 | $1.44M | Sell |
129,802
-35,203
| -21% | -$442K | ﹤0.01% | 1786 |
|
|
2023
Q1 | $2.53M | Buy |
165,005
+13,077
| +9% | +$288K | ﹤0.01% | 1560 |
|
|
2022
Q4 | $3.37M | Buy |
151,928
+10,678
| +8% | +$159K | ﹤0.01% | 1386 |
|
|
2022
Q3 | $2.31M | Buy |
141,250
+16,292
| +13% | +$312K | ﹤0.01% | 1555 |
|
|
2022
Q2 | $1.82M | Buy |
124,958
+2,442
| +2% | +$36.3K | ﹤0.01% | 1821 |
|
|
2022
Q1 | $2.26M | Sell |
122,516
-2,422
| -2% | -$41.1K | ﹤0.01% | 1811 |
|
|
2021
Q4 | $2.97M | Sell |
124,938
-220,372
| -64% | -$5.26M | ﹤0.01% | 1751 |
|
|
2021
Q3 | $8.51M | Buy |
345,310
+3,686
| +1% | +$80.1K | ﹤0.01% | 1227 |
|
|
2021
Q2 | $8.44M | Sell |
341,624
-132
| -0% | -$3.07K | ﹤0.01% | 1258 |
|
|
2021
Q1 | $7.45M | Buy |
341,756
+229,472
| +204% | +$5.62M | ﹤0.01% | 1345 |
|
|
2020
Q4 | $2.87M | Buy |
112,284
+3,348
| +3% | +$97.6K | ﹤0.01% | 1677 |
|
|
2020
Q3 | $3.07M | Buy |
108,936
+8,936
| +9% | +$258K | ﹤0.01% | 1491 |
|
|
2020
Q2 | $2.83M | Buy |
+100,000
| New | +$2.88M | ﹤0.01% | 1597 |
|
Other funds holding RNAM
Deutsche Bank's RNAM Position: Q1 2026 in Review
Deutsche Bank sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 166,841 shares — an estimated $12M sold.
Deutsche Bank first reported a position in RNAM in Q2 2020 and held it in 23 quarters. The position peaked at $12M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Deutsche Bank reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Deutsche Bank sold 166,841 Avidity Biosciences shares in Q1 2026, an estimated $12M.
- Deutsche Bank first reported a position in Avidity Biosciences in Q2 2020 and held it in 23 quarters.
- Deutsche Bank's Avidity Biosciences position peaked at $12M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.